Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by wildbird1on Aug 28, 2023 8:31am
454 Views
Post# 35607788

Interim Data...

Interim Data...Last year the update was on August 29,2022

The interim data for August 29,2022

            90 Day     180 Day     270 Day     360 Day    450 Day
CR           50%           47%            41%           35%          21%


The interim data for  May 31,2023
            90 Day     180 Day     270 Day     360 Day     450 Day
CR           60%          53%           43%            36%            33%
            (+20%)      (+14%)       (+5%)          (+4%)        (+55%)

The Interim data for August 29,2023???
             90 Day      180 Day     270 Day    360 Day     450 Day
                +?               +?              +?             +?             + ?
We can only predict that unlike Keytruda & Adstiladrin, it will not go down.




<< Previous
Bullboard Posts
Next >>